Totally agree. That is why a positive 28 readout is so critical, it will confirm that CYP has a commercial product that is safe. Hypothetically, if CYP decides to be a raw-product supplier to Bio-pharma, it would not have to fund any further FDA trials. There are many options open to the company to have early revenue streams. Fuji is just one of many revenue models.
Totally agree. That is why a positive 28 readout is so critical,...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $42.21M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.0¢ | $26.42K | 118.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 121149 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.0¢ | 24.0¢ | 9174 | ||
| Last updated 10.44am 06/05/2024 ? | |||||
| CYP (ASX) Chart |